Who has invested in Firefly Bio?

Versant Ventures, MPM BioImpact, Decheng Capital, Eli Lilly & Company are named among the investors backing Firefly Bio.

Firefly Bio Funding: $94M Raised, Series A (2024)

Firefly Bio funding overview

Firefly Bio is based in South San Francisco. Firefly Bio has raised $94M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2024. The round record for Firefly Bio runs through 2024; nothing later has been disclosed. Investors on record include Versant Ventures, MPM BioImpact, Decheng Capital, Eli Lilly & Company. 4 distinct backers are named across the disclosed rounds.

Firefly Bio at a glance

Total raised: $94M
Latest round: Series A
Latest round date: February 2024
Headquarters: South San Francisco
Notable investors: Versant Ventures, MPM BioImpact, Decheng Capital, Eli Lilly & Company

Frequently asked about Firefly Bio funding

How much has Firefly Bio raised?: Firefly Bio has raised $94M in total disclosed funding across the rounds on record.
Who has invested in Firefly Bio?: Versant Ventures, MPM BioImpact, Decheng Capital, Eli Lilly & Company are named among the investors backing Firefly Bio.
What was the latest Firefly Bio funding round?: The most recent disclosed round is a Series A, announced in February 2024.
Where is Firefly Bio based?: Firefly Bio is based in South San Francisco.
When did Firefly Bio last raise?: The last disclosed Firefly Bio round closed in February 2024 at Series A.

Totals shown for Firefly Bio aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.

Firefly Bio Funding: $94M Raised, Series A (2024)

Firefly Bio funding overview

Firefly Bio at a glance

Frequently asked about Firefly Bio funding

Companies related to Firefly Bio (36)

Browse related funding lists (5)